AeroLeads people directory · profile
Birgit Schultes Email & Phone Number
Intellia Therapeutics, Inc.
at
Intellia Therapeutics, Inc.
1 work email found
@intelliatx.com
5 phones found area 781 and 617
LinkedIn matched
4 data sources
Profile completeness 100%
Current company
Role
Intellia Therapeutics, Inc.
Location
Arlington, Massachusetts, United States
Company size
Who is Birgit Schultes? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Birgit Schultes is listed as Intellia Therapeutics, Inc. at Intellia Therapeutics, Inc., a company with 446 employees, based in Arlington, Massachusetts, United States. AeroLeads shows a work email signal at intelliatx.com, phone signal with area code 781, 617, and a matched LinkedIn profile for Birgit Schultes.
Birgit Schultes previously worked as Senior Vice President, Head of Cell Therapies at Intellia Therapeutics, Inc. and Vice President, Immunology (Cell Therapies) at Intellia Therapeutics, Inc.. Birgit Schultes holds Ph.D., Immunology from The University Of Bonn.
Company email context
Email format at Intellia Therapeutics, Inc.
This section adds company-level context without repeating Birgit Schultes's masked contact details.
{first}.{last}@intelliatx.com
89% confidence
AeroLeads found 1 current-domain work email signal for Birgit Schultes. Compare company email patterns before reaching out.
Profile bio
About Birgit Schultes
Specialties: oncology, immunology, antibodies, T cells, immune regulatory cells, dendritic cells
Listed skills include Assay Development, Immunology, In Vitro, Molecular Biology, and 46 others.
Current workplace
Birgit Schultes's current company
Company context helps verify the profile and gives searchers a useful next step.
Intellia Therapeutics, Inc.
12 roles
Birgit Schultes work experience
A career timeline built from the work history available for this profile.
Senior Vice President, Head Of Cell Therapies
Current
Oct 2021 - Present
Vice President, Immunology (Cell Therapies)
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.We are focused on the development of proprietary therapeutics using a recently developed biological tool known as the.
Sep 2017 - Oct 2021
Senior Director, In Vivo And Exploratory Immunology
"Unum" equals one. Formed in 2014, Unum Therapeutics is a Cambridge, Massachusetts-based cellular therapeutics company ushering in a new wave of innovation in cancer immunotherapy. Unum was built to transform cancer treatment through the discovery, development and commercialization of novel antibody-coupled cellular immunotherapies. Unum’s vision: a single.
Nov 2015 - Sep 2017
Senior Director
overseeing pharmacology and translational research in oncology and autoimmune diseases
Jan 2013 - Sep 2015
Director, Translational Research
Head a diverse group of in vitro and in vivo biologist and analytical scientists to transition development candidates through preclinical research into early clinical development. Responsible for disease specific animal models, dosing and dosing optimization, identification of target indications and patient populations, combination studies, biomarker.
Feb 2008 - Dec 2012
Director, Disease Biology
Responsible for assessing and manipulating biological functions of heparin and heparin sulfate derivatives in cancer, inflammatory diseases and cardiovascular indications; animal model development; lead drug identification
Apr 2008 - Jan 2011
Co-Founder And Scientific Advisor
Advanced Immune Therapeutics
The goal of the company is to produce novel cancer therapeutics for the potential benefit of all those touched by this devastating disease. Focus lies on novel approaches to induce curative immune responses to the tumor in combination with chemotherapeutics and/or biologic antagonists of immune suppressive pathways as well as on applying IgE antibodies to.
Jan 2008 - Dec 2012
Senior Director Research
Murine animal model developemnt (transgenic, transplantable and spontaneous models), cell-based in vitro system developent for antibody programs in ovarian, prostate and pancreatic cancer, combination regimes for chemo-immunotherapy, bioassay development and validation, eBLA preparation, project management, antibody engineering, translational biology.
Mar 2004 - Jan 2008
Director, Research And Clinical Immunology
Altarex Corp.
Target validation and identification of the mechanism of action of immune modulating agents in the fields of cancer, viral infections, autoimmune/inflammatory diseases and allergy, Project management for preclinical oncology antibodies, preclinical safety studies, development and validation of clinical assays, translational science
Sep 2000 - Mar 2004
Director, Preclinical Research
Altarex Corp.
directed a multi-disciplinary group of 15-20 scientists and technicians, responsible for hybridoma generation and characterization, antibody production, GLP safety studies, assay development, in vivo modeling and molecular biology groups, IND preparations
Jan 1998 - Sep 2000
Scientist
Altarex Corp.
Targeted photodynamic therapy with immunoliposomal formulation of Hypocrellinassay development, in vitro and in vivo characterization of cancer-specific antibodies and hybridoma clones
Jan 1996 - Dec 1997
4 education records
Birgit Schultes education
Ph.D., Immunology
The University Of Bonn
Advanced Management Development
Boston University
Project Management
Mbc
Masters, Biology
The University Of Bonn
FAQ
Frequently asked questions about Birgit Schultes
Quick answers generated from the profile data available on this page.
What company does Birgit Schultes work for?
Birgit Schultes works for Intellia Therapeutics, Inc..
What is Birgit Schultes's role at Intellia Therapeutics, Inc.?
Birgit Schultes is listed as Intellia Therapeutics, Inc. at Intellia Therapeutics, Inc..
What is Birgit Schultes's email address?
AeroLeads has found 1 work email signal at @intelliatx.com for Birgit Schultes at Intellia Therapeutics, Inc..
What is Birgit Schultes's phone number?
AeroLeads has found 5 phone signal(s) with area code 781, 617 for Birgit Schultes at Intellia Therapeutics, Inc..
Where is Birgit Schultes based?
Birgit Schultes is based in Arlington, Massachusetts, United States while working with Intellia Therapeutics, Inc..
What companies has Birgit Schultes worked for?
Birgit Schultes has worked for Intellia Therapeutics, Inc., Unum Therapeutics, Momenta Pharmaceuticals, Advanced Immune Therapeutics, and United Therapeutics.
How can I contact Birgit Schultes?
You can use AeroLeads to view verified contact signals for Birgit Schultes at Intellia Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Birgit Schultes attend?
Birgit Schultes holds Ph.D., Immunology from The University Of Bonn.
What skills is Birgit Schultes known for?
Birgit Schultes is listed with skills including Assay Development, Immunology, In Vitro, Molecular Biology, In Vivo, Biotechnology, Clinical Development, and Cell.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial